Remote patient monitoring sustains reductions of hemoglobin A1c in underserved patients to 12 months

AIMS: We sought to determine whether underserved patients enrolled in a statewide remote patient monitoring (RPM) program for diabetes achieve sustained improvements in hemoglobin A(1c) at 6 and 12 months and whether those improvements are affected by demographic and clinical variables. METHODS: Demographic and clinical variables were obtained at baseline, 6 months and 12 months. Baseline HbA1c values were compared with those obtained at 6 and 12 months via paired t-tests. A multivariable regression model was developed to identify patient-level variables associated with HbA(1c) change at 12 months. RESULTS: HbA(1c) values were obtained for 302 participants at 6 months and 125 participants at 12 months. Compared to baseline, HbA(1c) values were 1.8% (19mmol/mol) lower at 6 months (p